Core Laboratories Inc. — Earnings Quality Grade F
CLB · Energy
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 79 days, change +1 days YoY
AR growth 1.6% vs revenue growth 0.5%
Revenue 0.5%, CFFO -34.3%. Cash follows revenue
Expense Quality
Inventory -8.3% vs COGS -0.7%. Normal
CapEx growth 13.1% vs revenue 0.5%. Normal
SG&A/Gross Profit = 46.9%. Normal
Gross margin 17.9%, change +1.0pp. Stable
Cash Flow Quality
CFFO/NI = 1.25. Profits backed by cash
FCF $0.0B, FCF/NI = 0.75
Accruals ratio = -1.3%. Low accruals
Cash $0.0B covers only 14% of debt $0.2B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 42% of equity
Debt/EBITDA = 2.3x. Healthy
Other assets 3.8% vs revenue 0.5%. Normal
Write-offs normal
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 7% YoY. Normal
Manipulation Score
M-Score = -2.55 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor CLB continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25